ReNeuron Group: Year-End Update Highlights Transaction Potential
ReNeuron (LON:RQE)’s year-end update summarised its recent clinical progress in the human retinal progenitor cell (hRPC) programme in retinitis pigmentosa (RP), which has...
Symbol | Exchange | Currency |
|---|
ReNeuron (LON:RQE)’s year-end update summarised its recent clinical progress in the human retinal progenitor cell (hRPC) programme in retinitis pigmentosa (RP), which has...
Following-on from ReNeuron Group PLC (LON:RQE)’s recent striking early-stage data release for its human retinal progenitor cell (hRPC) product in retinitis pigmentosa (RP),...
ReNeuron Group PLC (LON:RQE)’s announcement of early but exciting data on three patients in the clinical study of its human retinal progenitor cell (hRPC) product was well...
ReNeuron Group plc is a United Kingdom-based Stem Cell and Exosome Technologies company that utilizes its stem cell technologies to develop treatments for disease with unmet needs. The Company’s stem cell derived Exosome Technology platform offers a delivery mechanism for a variety of payloads, such as small interfering Ribonucleic Acid (siRNA), messenger RNA (mRNA), proteins, small molecules and genes. The Company has two clinical-stage stem cell therapy candidate assets, a Phase 2a human retinal progenitor cell (hRPC) therapy candidate in retinitis pigmentosa and a Phase 2b immortalized neural progenitor cell therapy candidate (CTX) in stroke. The Company through its induced pluripotent stem cell (iPSC) platform has the ability to make allogeneic tissue cells of choice and has the potential to produce exosomes with tissue specific targeting ability.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Sell | Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Buy | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Neutral | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 150.82 | 151.18 | 148.17 | +5.39 | +3.71% | 101.39M | NASDAQ | |||
| 112.91 | 114.00 | 108.88 | +7.76 | +7.38% | 142.72M | NASDAQ | |||
| 53.70 | 54.00 | 53.70 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 25.81 | 25.89 | 25.49 | +0.13 | +0.51% | 4.61M | NYSE | |||
| 188.27 | 196.75 | 182.61 | +6.86 | +3.78% | 214.41M | NASDAQ | |||
| 264.60 | 264.69 | 257.25 | +11.85 | +4.69% | 39.04M | NASDAQ | |||
| 107.74 | 107.85 | 105.61 | +7.31 | +7.28% | 65.06M | NASDAQ | |||
| 188.77 | 197.16 | 180.16 | +35.65 | +23.28% | 149.57M | NASDAQ | |||
| 88.41 | 89.97 | 86.22 | +4.51 | +5.38% | 13.23M | NYSE | |||
| 73.07 | 74.20 | 72.68 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 217.09 | 219.49 | 207.00 | +7.66 | +3.66% | 55.78M | NASDAQ | |||
| 37.05 | 37.97 | 36.82 | -0.67 | -1.78% | 862.76K | NYSE | |||
| 40.59 | 41.01 | 40.52 | -0.13 | -0.32% | 3.43M | NYSE | |||
| 0.127 | 0.139 | 0.123 | -0.004 | -3.27% | 4.08M | OTC Markets | |||
| 8.03 | 8.39 | 7.90 | -0.10 | -1.23% | 8.52M | NYSE |